Developer docs
API playgroundTry for free, no card

Search company profiles

National Centre for Immunisation Research and Surveillance

Full company profile

uuid002841j

Namestring
National Centre for Immunisation Research and Surveillance
Legal namestring
National Centre for Immunisation Research and Surveillance
Websiteurl
ncirs.org.au
Company typeenum
Private
Founded yearint
2000
Descriptiontext

The National Centre for Immunisation Research and Surveillance (NCIRS) is an Australian non-profit research organisation established in 2000 (with earlier origins dated to 1997) and hosted within the Sydney Children's Hospitals Network (SCHN) at Kids Research, Westmead, NSW. It is primarily funded by the Australian Government Department of Health and Aged Care and provides expert evidence and advice on vaccine-preventable diseases, immunisation coverage, and vaccine safety to inform federal and state health policy. NCIRS operates as a publicly funded, mission-driven entity rather than a commercial business; all publications, guidelines, and resources on its website are provided free of charge.

NCIRS' core operational portfolio comprises four flagship platforms: AusVaxSafety, a national active vaccine safety surveillance system monitoring adverse events following immunisation across all National Immunisation Program vaccines; PAEDS (Paediatric Active Enhanced Disease Surveillance), a hospital-based paediatric surveillance network; the Australian Immunisation Handbook, the authoritative clinical reference for immunisation providers in Australia; and SKAI (Sharing Knowledge About Immunisation), an evidence-based communication resource. Supporting offerings include the NSW Immunisation Specialist Service (NSWISS), the PHN Immunisation Support Program, the National Vaccination Insights Project (social science research on vaccination barriers), and annual Immunisation Coverage Reports derived from Australian Immunisation Register data analysis.

The organisation serves health professionals, government policymakers, and the general public, and operates a global health program delivering technical assistance to WHO, Gavi, UNICEF, and Pacific nation governments (Timor-Leste, Solomon Islands, Papua New Guinea). NCIRS functions through institutional/government channels rather than commercial sales, with revenue derived from federal grants, state health contracts, and multilateral project funding. Director Professor Kristine Macartney sits on the WHO Global Advisory Committee on Vaccine Safety, and NCIRS provides the technical secretariat for ATAGI. Headcount is reported at 51–100 staff, organised across clinical research, surveillance, policy support, social science, and global health teams.

Short descriptiontext

NCIRS is a publicly funded Australian non-profit research organisation, hosted within Sydney Children's Hospitals Network, that conducts immunisation research, disease surveillance, and policy support for the federal government, WHO, Gavi, UNICEF, and Pacific-region health authorities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersWestmead, Australia
HQ citystring
Westmead
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
immunisation research services, vaccine safety surveillance, clinical immunisation guidelines, paediatric disease surveillance, immunisation policy support
Industry1 code
1Immunization & Vaccination Programs Administration
CodeBPAIAJADPrimaryYes
NAICS code1 code
  • Other Scientific and Technical Consulting Services541690
Product category
Public Health Immunisation Research and Surveillance
Social media profiles1 record
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

NCIRS is Australia's leading immunisation research organisation. It provides expert evidence and advice on vaccine-preventable diseases through active surveillance systems (AusVaxSafety, PAEDS), clinical guidelines (Australian Immunisation Handbook), communication resources (SKAI), social science research, and policy support. Its services are aimed at health professionals, government health departments, and the broader public.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • NCIRS Annual Immunisation Coverage Report tracks vaccination rates for children, adolescents and adults across Australia
+1 more record
Product overview1 text field

NCIRS provides a comprehensive suite of immunisation research, surveillance, and education products and services. The core offerings include AusVaxSafety for vaccine safety surveillance, PAEDS for paediatric disease surveillance, the Australian Immunisation Handbook as the authoritative clinical resource, and SKAI for community and provider communication. Clinical services such as NSWISS offer specialist immunisation advice. The National Vaccination Insights Project conducts social science research on vaccination barriers, while NCIRS also publishes annual immunisation coverage reports and produces the Weekly Jab Newsletter for immunisation professionals.

Product and service8 records
1AusVaxSafety
CategoryVaccine safety surveillance
Description

National active vaccine safety surveillance system that monitors adverse events following immunisation across all National Immunisation Program vaccines in Australia. Built for health professionals and the public to ensure vaccine safety and maintain public confidence.

2PAEDS (Paediatric Active Enhanced Disease Surveillance)
CategoryPaediatric disease surveillance
Description

Hospital-based active surveillance network for serious childhood diseases including acute flaccid paralysis and other vaccine-preventable conditions, coordinated across multiple Australian children's hospitals.

3Australian Immunisation Handbook
CategoryClinical guidelines
Description

Authoritative online clinical resource providing evidence-based recommendations for immunisation in Australia, used by immunisation providers, GPs and other health professionals as the national clinical reference.

4SKAI (Sharing Knowledge About Immunisation)
CategoryImmunisation communication
Description

Digital communication package providing reliable, tailored information about immunisation for both health professionals and the community to support vaccination conversations and decisions.

5NSW Immunisation Specialist Service (NSWISS)
CategorySpecialist clinical service
Description

Specialist clinical service providing expert advice and support for complex immunisation challenges, including assessment and management of adverse events following immunisation, for immunisation providers across NSW.

6NCIRS Weekly Jab Newsletter
CategoryProfessional information service
Description

Weekly email newsletter providing immunisation professionals with the latest NCIRS resources, news, media, events, publications and career opportunities in immunisation.

7National Vaccination Insights Project
CategorySocial science research
Description

Social science research initiative examining barriers to vaccination uptake among children and adults through nationally representative surveys and qualitative studies conducted in partnership with the Murdoch Children's Research Institute.

8Immunisation Coverage Reports
CategoryCoverage data and reporting
Description

Annual analysis and reporting on vaccination coverage for children, adolescents and adults across Australia, using Australian Immunisation Register data and additional national data sources.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

NCIRS partnered with UNICEF to support the Solomon Islands HPV Big Catch-Up campaign, contributing to 79.4% vaccination coverage.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

NCIRS worked with PATH on the Solomon Islands HPV vaccine Big Catch-Up campaign as part of the South Pacific nation's immunisation program.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

DFAT funding supports NCIRS technical assistance in Papua New Guinea outbreak response, including assessment, surveillance strengthening and evaluation frameworks for polio immunisation rounds.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NCIRS is a member of WHO's Vaccine Safety Net and its Director serves on the WHO Global Advisory Committee on Vaccine Safety (GACVS) and WHO-SAGE subcommittees. NCIRS collaborates with WHO on international immunisation initiatives.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Gavi funding supports NCIRS global health initiatives including the BeSD study in Timor-Leste to understand barriers to childhood vaccination.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NCIRS collaborates with Menzies on global health research, including the BeSD study in Timor-Leste and tropical health research initiatives.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NCIRS has conjoint academic appointments with the University of Sydney. Director Kristine Macartney holds a professorial appointment in the Discipline of Child and Adolescent Health at University of Sydney.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NCIRS is hosted within the Sydney Children's Hospitals Network at Kids Research, providing clinical and academic integration with The Children's Hospital at Westmead.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NCIRS collaborates with MCRI on the National Vaccination Insights project, conducting nationally representative surveys of parents on childhood vaccination barriers.

10AusVaxSafety
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NCIRS hosts and operates AusVaxSafety, Australia's national vaccine safety surveillance system, in partnership with state/territory health departments.

ncirs.org.au
11PAEDS (Paediatric Active Enhanced Disease Surveillance)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NCIRS hosts PAEDS, a hospital-based surveillance network for serious childhood diseases, coordinated across multiple children's hospitals.

ncirs.org.au
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based non-profit focused on vaccine research, immunisation advocacy, and vaccine education/communications. Sabin shares NCIRS's mission around vaccine confidence and acceptance, runs Boost (a comparable immunisation community platform), and works globally on immunisation policy.

TypeBroad incumbent
Description

EU agency providing epidemiological surveillance, scientific advice, and immunisation guidance for Europe. ECDC operates a continental vaccine surveillance and coverage mandate comparable to NCIRS's domestic role, with broader multi-country scope but a similar evidence-to-policy translation function.

TypeBroad incumbent
Description

UK government agency responsible for public health protection including immunisation surveillance, vaccine safety, and epidemiology. UKHSA performs an analogous role to NCIRS for the UK (post-public-health split from PHE) and operates national vaccine surveillance systems, clinical guidelines, and outbreak response — a closely comparable public-health remit at national scale.

TypeBroad incumbent
Description

US federal public health agency that performs disease surveillance, vaccine safety monitoring, and immunisation policy support at national scale. CDC is a much larger, broader public health incumbent with overlapping capabilities in vaccine safety (VAERS, VSD), epidemiology, and immunisation guidance — but covers a vastly wider portfolio than NCIRS.

TypeDirect peer
Description

Western Australia-based paediatric research institute with infectious disease, vaccine, and Aboriginal child health research portfolios. Telethon Kids shares NCIRS's model of paediatric infectious disease research embedded in a children's hospital network, with overlapping vaccine preventable disease and Aboriginal immunisation work.

TypeDirect peer
Description

Global non-profit focused on health equity, vaccine introduction, and immunisation programme strengthening. PATH is an established NCIRS partner (Solomon Islands HPV Big Catch-Up 2025) and shares the model of a multi-country technical assistance provider supporting LMIC immunisation programmes.

TypeDirect peer
Description

US-based non-profit working on immunisation programme strengthening, vaccine financing, and surveillance/elimination efforts (e.g., polio, measles). The Task Force operates a comparable global health mandate focused on immunisation delivery and is a peer in the international immunisation ecosystem alongside NCIRS.

TypeDirect peer
Description

Australia's largest child health research institute, hosted at the Royal Children's Hospital in Melbourne. MCRI is a direct NCIRS collaborator on the National Vaccination Insights project and shares paediatric infectious disease research, vaccine safety, and immunisation social science mandates — operating a comparable academic/government hybrid model.

TypeDirect peer
Description

Australian medical research and public health institute focused on infectious disease, vaccines, and global health. Burnet pursues similar translational research and global health advisory work, with overlapping subject matter expertise (vaccine development, immunisation in LMICs, public health policy support).

TypeDirect peer
Description

New Zealand's national immunisation advisory and education centre, hosted at the University of Auckland. IMAC is the closest functional peer in scope and scale — providing clinical immunisation guidance, workforce education, and vaccine safety support, primarily for one country with regional reach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

National Centre for Immunisation Research and Surveillance

Public Health Immunisation Research and Surveillancencirs.org.au

NCIRS is a publicly funded Australian non-profit research organisation, hosted within Sydney Children's Hospitals Network, that conducts immunisation research, disease surveillance, and policy support for the federal government, WHO, Gavi, UNICEF, and Pacific-region health authorities.

What National Centre for Immunisation Research and Surveillance does

The National Centre for Immunisation Research and Surveillance (NCIRS) is an Australian non-profit research organisation established in 2000 (with earlier origins dated to 1997) and hosted within the Sydney Children's Hospitals Network (SCHN) at Kids Research, Westmead, NSW. It is primarily funded by the Australian Government Department of Health and Aged Care and provides expert evidence and advice on vaccine-preventable diseases, immunisation coverage, and vaccine safety to inform federal and state health policy. NCIRS operates as a publicly funded, mission-driven entity rather than a commercial business; all publications, guidelines, and resources on its website are provided free of charge.

NCIRS' core operational portfolio comprises four flagship platforms: AusVaxSafety, a national active vaccine safety surveillance system monitoring adverse events following immunisation across all National Immunisation Program vaccines; PAEDS (Paediatric Active Enhanced Disease Surveillance), a hospital-based paediatric surveillance network; the Australian Immunisation Handbook, the authoritative clinical reference for immunisation providers in Australia; and SKAI (Sharing Knowledge About Immunisation), an evidence-based communication resource. Supporting offerings include the NSW Immunisation Specialist Service (NSWISS), the PHN Immunisation Support Program, the National Vaccination Insights Project (social science research on vaccination barriers), and annual Immunisation Coverage Reports derived from Australian Immunisation Register data analysis.

The organisation serves health professionals, government policymakers, and the general public, and operates a global health program delivering technical assistance to WHO, Gavi, UNICEF, and Pacific nation governments (Timor-Leste, Solomon Islands, Papua New Guinea). NCIRS functions through institutional/government channels rather than commercial sales, with revenue derived from federal grants, state health contracts, and multilateral project funding. Director Professor Kristine Macartney sits on the WHO Global Advisory Committee on Vaccine Safety, and NCIRS provides the technical secretariat for ATAGI. Headcount is reported at 51–100 staff, organised across clinical research, surveillance, policy support, social science, and global health teams.

National Centre for Immunisation Research and Surveillance firmographics

Firmographics
Name
National Centre for Immunisation Research and Surveillance
Legal name
National Centre for Immunisation Research and Surveillance
Website
https://ncirs.org.au
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
51–100 employees
Short description
NCIRS is a publicly funded Australian non-profit research organisation, hosted within Sydney Children's Hospitals Network, that conducts immunisation research, disease surveillance, and policy support for the federal government, WHO, Gavi, UNICEF, and Pacific-region health authorities.
Ownership category
akta.pro rank

National Centre for Immunisation Research and Surveillance industry classification

Industry
Product category
Public Health Immunisation Research and Surveillance
NAICS
Other Scientific and Technical Consulting Services (541690)
akta.pro primary industry
Immunization & Vaccination Programs Administration (BPAIAJAD)

Keywords

  • Immunisation research services
  • Vaccine safety surveillance
  • Clinical immunisation guidelines
  • Paediatric disease surveillance
  • Immunisation policy support

Where National Centre for Immunisation Research and Surveillance is headquartered

Location

Headquarters

HQ city
Westmead
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

National Centre for Immunisation Research and Surveillance business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Others

Distribution channels3 records

Marketing channels5 records

National Centre for Immunisation Research and Surveillance product offering

Product offering

Core offering

NCIRS is Australia's leading immunisation research organisation. It provides expert evidence and advice on vaccine-preventable diseases through active surveillance systems (AusVaxSafety, PAEDS), clinical guidelines (Australian Immunisation Handbook), communication resources (SKAI), social science research, and policy support. Its services are aimed at health professionals, government health departments, and the broader public.

Product overview

NCIRS provides a comprehensive suite of immunisation research, surveillance, and education products and services. The core offerings include AusVaxSafety for vaccine safety surveillance, PAEDS for paediatric disease surveillance, the Australian Immunisation Handbook as the authoritative clinical resource, and SKAI for community and provider communication. Clinical services such as NSWISS offer specialist immunisation advice. The National Vaccination Insights Project conducts social science research on vaccination barriers, while NCIRS also publishes annual immunisation coverage reports and produces the Weekly Jab Newsletter for immunisation professionals.

Differentiator

Problem solved

Functional benefit

Products and services

  • AusVaxSafety National active vaccine safety surveillance system that monitors adverse events following immunisation across all National Immunisation Program vaccines in Australia. Built for health professionals and the public to ensure vaccine safety and maintain public confidence.
  • PAEDS (Paediatric Active Enhanced Disease Surveillance) Hospital-based active surveillance network for serious childhood diseases including acute flaccid paralysis and other vaccine-preventable conditions, coordinated across multiple Australian children's hospitals.
  • Australian Immunisation Handbook Authoritative online clinical resource providing evidence-based recommendations for immunisation in Australia, used by immunisation providers, GPs and other health professionals as the national clinical reference.
  • SKAI (Sharing Knowledge About Immunisation) Digital communication package providing reliable, tailored information about immunisation for both health professionals and the community to support vaccination conversations and decisions.
  • NSW Immunisation Specialist Service (NSWISS) Specialist clinical service providing expert advice and support for complex immunisation challenges, including assessment and management of adverse events following immunisation, for immunisation providers across NSW.
  • NCIRS Weekly Jab Newsletter Weekly email newsletter providing immunisation professionals with the latest NCIRS resources, news, media, events, publications and career opportunities in immunisation.
  • National Vaccination Insights Project Social science research initiative examining barriers to vaccination uptake among children and adults through nationally representative surveys and qualitative studies conducted in partnership with the Murdoch Children's Research Institute.
  • Immunisation Coverage Reports Annual analysis and reporting on vaccination coverage for children, adolescents and adults across Australia, using Australian Immunisation Register data and additional national data sources.

Quantifiable outcome

  • NCIRS Annual Immunisation Coverage Report tracks vaccination rates for children, adolescents and adults across Australia
  • +1 more outcomes

Companies that use National Centre for Immunisation Research and Surveillance

Customer profile

Segments3 records

Ideal customer profiles3 records

National Centre for Immunisation Research and Surveillance technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

National Centre for Immunisation Research and Surveillance partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and major.

  • UNICEFcoreStrategic or Co-development Partner · 1 January 2025NCIRS partnered with UNICEF to support the Solomon Islands HPV Big Catch-Up campaign, contributing to 79.4% vaccination coverage.
  • PATHmajorStrategic or Co-development Partner · 1 January 2025NCIRS worked with PATH on the Solomon Islands HPV vaccine Big Catch-Up campaign as part of the South Pacific nation's immunisation program.
  • Australian Department of Foreign Affairs and Trade (DFAT)coreStrategic or Co-development Partner · 1 January 2025DFAT funding supports NCIRS technical assistance in Papua New Guinea outbreak response, including assessment, surveillance strengthening and evaluation frameworks for polio immunisation rounds.
  • World Health Organization (WHO)coreStrategic or Co-development PartnerNCIRS is a member of WHO's Vaccine Safety Net and its Director serves on the WHO Global Advisory Committee on Vaccine Safety (GACVS) and WHO-SAGE subcommittees. NCIRS collaborates with WHO on international immunisation initiatives.
  • Gavi, the Vaccine AlliancecoreStrategic or Co-development PartnerGavi funding supports NCIRS global health initiatives including the BeSD study in Timor-Leste to understand barriers to childhood vaccination.
  • Menzies School of Health ResearchcoreStrategic or Co-development PartnerNCIRS collaborates with Menzies on global health research, including the BeSD study in Timor-Leste and tropical health research initiatives.
  • University of SydneycoreStrategic or Co-development PartnerNCIRS has conjoint academic appointments with the University of Sydney. Director Kristine Macartney holds a professorial appointment in the Discipline of Child and Adolescent Health at University of Sydney.
  • Sydney Children's Hospitals NetworkcoreStrategic or Co-development PartnerNCIRS is hosted within the Sydney Children's Hospitals Network at Kids Research, providing clinical and academic integration with The Children's Hospital at Westmead.
  • Murdoch Children's Research InstitutecoreStrategic or Co-development PartnerNCIRS collaborates with MCRI on the National Vaccination Insights project, conducting nationally representative surveys of parents on childhood vaccination barriers.
  • AusVaxSafetycoreStrategic or Co-development PartnerNCIRS hosts and operates AusVaxSafety, Australia's national vaccine safety surveillance system, in partnership with state/territory health departments.
  • PAEDS (Paediatric Active Enhanced Disease Surveillance)coreStrategic or Co-development PartnerNCIRS hosts PAEDS, a hospital-based surveillance network for serious childhood diseases, coordinated across multiple children's hospitals.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

National Centre for Immunisation Research and Surveillance competitors and assessment

Company assessment

Direct peers

  • Sabin Vaccine Institute: US-based non-profit focused on vaccine research, immunisation advocacy, and vaccine education/communications. Sabin shares NCIRS's mission around vaccine confidence and acceptance, runs Boost (a comparable immunisation community platform), and works globally on immunisation policy.
  • Telethon Kids Institute: Western Australia-based paediatric research institute with infectious disease, vaccine, and Aboriginal child health research portfolios. Telethon Kids shares NCIRS's model of paediatric infectious disease research embedded in a children's hospital network, with overlapping vaccine preventable disease and Aboriginal immunisation work.
  • PATH: Global non-profit focused on health equity, vaccine introduction, and immunisation programme strengthening. PATH is an established NCIRS partner (Solomon Islands HPV Big Catch-Up 2025) and shares the model of a multi-country technical assistance provider supporting LMIC immunisation programmes.
  • Task Force for Global Health: US-based non-profit working on immunisation programme strengthening, vaccine financing, and surveillance/elimination efforts (e.g., polio, measles). The Task Force operates a comparable global health mandate focused on immunisation delivery and is a peer in the international immunisation ecosystem alongside NCIRS.
  • Murdoch Children's Research Institute (MCRI): Australia's largest child health research institute, hosted at the Royal Children's Hospital in Melbourne. MCRI is a direct NCIRS collaborator on the National Vaccination Insights project and shares paediatric infectious disease research, vaccine safety, and immunisation social science mandates — operating a comparable academic/government hybrid model.
  • Burnet Institute: Australian medical research and public health institute focused on infectious disease, vaccines, and global health. Burnet pursues similar translational research and global health advisory work, with overlapping subject matter expertise (vaccine development, immunisation in LMICs, public health policy support).
  • Immunisation Advisory Centre (IMAC), New Zealand: New Zealand's national immunisation advisory and education centre, hosted at the University of Auckland. IMAC is the closest functional peer in scope and scale — providing clinical immunisation guidance, workforce education, and vaccine safety support, primarily for one country with regional reach.

Broad incumbents

  • European Centre for Disease Prevention and Control (ECDC): EU agency providing epidemiological surveillance, scientific advice, and immunisation guidance for Europe. ECDC operates a continental vaccine surveillance and coverage mandate comparable to NCIRS's domestic role, with broader multi-country scope but a similar evidence-to-policy translation function.
  • UK Health Security Agency (UKHSA): UK government agency responsible for public health protection including immunisation surveillance, vaccine safety, and epidemiology. UKHSA performs an analogous role to NCIRS for the UK (post-public-health split from PHE) and operates national vaccine surveillance systems, clinical guidelines, and outbreak response — a closely comparable public-health remit at national scale.
  • Centers for Disease Control and Prevention (CDC): US federal public health agency that performs disease surveillance, vaccine safety monitoring, and immunisation policy support at national scale. CDC is a much larger, broader public health incumbent with overlapping capabilities in vaccine safety (VAERS, VSD), epidemiology, and immunisation guidance — but covers a vastly wider portfolio than NCIRS.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

National Centre for Immunisation Research and Surveillance social profiles

Digital presence

National Centre for Immunisation Research and Surveillance financial estimates

Financial estimate

Revenue estimate

Valuation estimate

National Centre for Immunisation Research and Surveillance leadership team

Management profile

Number of profiles

Profiles10 records

National Centre for Immunisation Research and Surveillance subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

National Centre for Immunisation Research and Surveillance funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

National Centre for Immunisation Research and Surveillance M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Centre for Immunisation Research and Surveillance

What does National Centre for Immunisation Research and Surveillance do?

NCIRS is Australia's leading immunisation research organisation. It provides expert evidence and advice on vaccine-preventable diseases through active surveillance systems (AusVaxSafety, PAEDS), clinical guidelines (Australian Immunisation Handbook), communication resources (SKAI), social science research, and policy support. Its services are aimed at health professionals, government health departments, and the broader public.

Is National Centre for Immunisation Research and Surveillance a public or private company?

National Centre for Immunisation Research and Surveillance is a private company. It is classified as state government owned and is currently operating.

When was National Centre for Immunisation Research and Surveillance founded?

National Centre for Immunisation Research and Surveillance was founded in 2000. It employs 51 to 100 people.

Where is National Centre for Immunisation Research and Surveillance based?

National Centre for Immunisation Research and Surveillance is headquartered in Westmead, Australia, in the Oceania region.

Who are National Centre for Immunisation Research and Surveillance's main competitors?

Direct peers on record are Sabin Vaccine Institute, Telethon Kids Institute, PATH, Task Force for Global Health, Murdoch Children's Research Institute (MCRI), Burnet Institute and Immunisation Advisory Centre (IMAC), New Zealand. Broad incumbents are European Centre for Disease Prevention and Control (ECDC), UK Health Security Agency (UKHSA) and Centers for Disease Control and Prevention (CDC).

Does National Centre for Immunisation Research and Surveillance have an API?

No public API is recorded for National Centre for Immunisation Research and Surveillance.

What industry is National Centre for Immunisation Research and Surveillance in?

National Centre for Immunisation Research and Surveillance's product category is Public Health Immunisation Research and Surveillance. Its primary akta.pro industry code is BPAIAJAD, Immunization & Vaccination Programs Administration. Its NAICS code is 541690.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The AustralianMeasles immunity study reveals how many Australians are at riskA landmark study led by the National Centre for Immunisation Research and Surveillance found that approximately 1.7 million Australians, or 6.7% of the population, lacked sufficient measles immunity in 2019. With measles notifications rising sharply to 181 cases in 2025 and 113 so far in 2026, researchers warn that declining vaccination rates since the pandemic have narrowed the margin for herd protection.Mirage News1.7M Australians at Risk of Measles OutbreakA study led by the National Centre for Immunisation Research and Surveillance (NCIRS) reveals that 1.7 million Australians, or 6.7% of the population, lacked sufficient measles immunity in 2019, a figure likely higher today due to declining childhood vaccination rates. National measles notifications have risen sharply from single figures to 181 cases in 2025 and 113 so far in 2026, prompting warnings about potential outbreaks linked to overseas travel. Experts emphasize the need for specific demographics, particularly travelers and those born after 1977, to verify their vaccination status to maintain Australia's measles elimination status.ABCWarnings of possible measles outbreak as study finds 1.7 million Australians are vulnerableA study by the National Centre for Immunisation Research and Surveillance (NCIRS) indicates that approximately 1.7 million Australians are susceptible to measles, putting the country at risk of significant outbreaks due to immunity levels below the World Health Organization's target. The analysis highlights that over 80,000 children under five are not fully vaccinated and identifies specific generational cohorts with high susceptibility resulting from historical gaps in immunization programs.MjaHow flu vaccines are monitored for safetyResearchers from the Therapeutic Goods Administration (TGA), the National Centre for Immunisation Research and Surveillance, and the Telethon Kids Institute have outlined Australia's pharmacovigilance processes for monitoring seasonal influenza vaccine safety. The article highlights that approximately 9 million flu vaccines were administered in Australia in 2023 and details the collaborative surveillance methods used to detect adverse events following immunisation. It also addresses challenges such as under-reporting and notes ongoing efforts by the TGA to improve data quality and practitioner engagement.